AGIC Capital-led group to buy Ritedose

A consortium led by AGIC Capital has agreed to buy The Ritedose Corp. Olympus Partners is the seller. The deal is valued at between $600 million to $800 million, press reports said. Ritedose, of Columbia, South Carolina, is a contract pharmaceutical manufacturer.

DealsNorth AmericaUSBriefs